P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009

Creator: Fenyö, Eva Maria

Contributor: Holmgren, B.
da Silva, ZJ
Nielsen, J.
Aaby, P.
Jansson, M.
SpringerLink (Online service)

DOI: 10.1186/1742-4690-6-S3-P74

URN: urn:nbn:de:1111-201608077950

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fenyö, Eva Maria
Holmgren, B.
da Silva, ZJ
Nielsen, J.
Aaby, P.
Jansson, M.
SpringerLink (Online service)

Other Objects (12)

Broadly Neutralizing Antibodies for HIV Eradication

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Identification of individuals with broadly neutralizing serum activity against HIV-1

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

The expanding array of HIV broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Identification of a novel broadly neutralizing antibody targeting HIV-1

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Identification of individuals with broadly neutralizing serum activity against HIV-1

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

The expanding array of HIV broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Identification of a novel broadly neutralizing antibody targeting HIV-1

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Identification of individuals with broadly neutralizing serum activity against HIV-1

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

The expanding array of HIV broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Identification of a novel broadly neutralizing antibody targeting HIV-1

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Broadly Neutralizing Antibodies for HIV Eradication

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Identification of individuals with broadly neutralizing serum activity against HIV-1

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

The expanding array of HIV broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Identification of a novel broadly neutralizing antibody targeting HIV-1

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Identification of individuals with broadly neutralizing serum activity against HIV-1

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

The expanding array of HIV broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Identification of a novel broadly neutralizing antibody targeting HIV-1

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Identification of individuals with broadly neutralizing serum activity against HIV-1

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

Characterization of V1/V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

The expanding array of HIV broadly neutralizing antibodies

Vaccination induces broadly neutralizing antibody precursors to HIV gp41

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Identification of a novel broadly neutralizing antibody targeting HIV-1

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Related objects

Reset password